New capsule trial targets severe eczema itch and rash
NCT ID NCT07344051
Summary
This study is testing whether QLS12010 capsules can safely reduce the severity of eczema and itching in adults with moderate-to-severe atopic dermatitis. About 160 participants will receive either the experimental capsules or a placebo for 16 weeks to compare results. The trial aims to see if this new treatment can significantly improve skin condition and quality of life for people struggling with this chronic skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.